2017 | The Wall Street Analyzer - Part 19

Latest News

[ October 24, 2025 ] Gunnison Copper Reports Positive Results from Limestone Evaluation to Add New By-Product Revenue at the Gunnison Project in Southeast Arizona News Feed
[ October 16, 2025 ] Rain Enhancement Technologies Strengthens Strategic Leadership with Quantum Physics Pioneer and Corporate Governance Expert News Feed
[ October 16, 2025 ] Terra Clean’s Fraser Lakes B Deposit Contains Significant Rare Earth Element Potential and is Listed as an Active Government of Canada Rare Earth Deposit News Feed
[ October 7, 2025 ] Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma News Feed
[ October 3, 2025 ] SafeSpace Global Expands AI Safety Technology to Protect Schools and Public Spaces News Feed
[ October 3, 2025 ] Midnight Sun Announces C$10 Million “Bought Deal” Life Offering and Private Placement of Units News Feed
[ September 30, 2025 ] Borealis Announces First Gold Pour News Feed

No Picture

Neurotrope BioScience (OTCQB:NTRP) CEO Interview

February 1, 2017 The Wall Street Analyzer Comments Off

Interview with Susanne Wilke, CEO […]

No Picture

Gevo, Inc (NASDAQ: GEVO) CEO Interview

January 26, 2017 The Wall Street Analyzer Comments Off

Interview with Patrick Gruber, CEO […]

No Picture

Lexaria Bioscience (OTCQB:LXRP) (CSE:LXX) CEO Interview

January 25, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Chris Bunka […]

No Picture

Park Place Energy (OTCQB: PKPL) CEO Interview

January 25, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Scott Larsen […]

No Picture

Tamarack Valley Energy Ltd. (TSX: TVE) CEO Interview

January 24, 2017 The Wall Street Analyzer Comments Off

Interview with Brian Schmidt, CEO […]

No Picture

Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) CEO Interview

January 24, 2017 The Wall Street Analyzer Comments Off

Interview with Marc Voight, CEO […]

No Picture

Aphria, Inc. (TSXV: APH) (OTCQB: APHQF) Management Interview

January 19, 2017 The Wall Street Analyzer Comments Off

Interview with Carl Merton, CFO […]

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) CEO Interview Update

January 18, 2017 The Wall Street Analyzer Comments Off

Interview update with Jeffrey Bacha, CEO […]

No Picture

AudioEye, Inc. (OTCQB: AEYE) CEO INTERVIEW

January 12, 2017 The Wall Street Analyzer Comments Off

Interview with Todd Bankofier, CEO […]

ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) CEO Interview

January 9, 2017 The Wall Street Analyzer 1

Interview update with CEO James Sapirstein […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com